COLINZ logo

Colinz Laboratories Ltd

COLINZ·BSE·
72.56 +1.06 (+1.48%)
Market Cap17.54 Cr
PE Ratio36.65
Volume47
Day High - Low73.65 - 72.56
52W High-Low87.91 - 36.11
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
5.30%
Weak
P/E
36.65x
Expensive
Debt / Equity
0.04
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day72.56
73.65
52W36.11
87.91
DocStoX take

Supported by momentum (7.5) and risk (6.7), but held back by valuation (2.7). Momentum looks strong at 7.5, but that is offset by valuation at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.1
/10
Weak
Quality
Modest
ROE 5.3%
Valuation
Expensive
P/E 36.6×
Growth
Steady
Revenue +1.4% 5Y CAGR
Risk
Moderate
D/E 0.04
Momentum
Strong
70% of 52-week range

At a glance

Market Cap
₹18 Cr
52W High / Low
₹88 / ₹36
Dividend Yield
0.00%
Promoter Holding
50.60%
EPS (TTM)
₹1.98
Book Value
₹69.74

Key highlights

  • Low leverage — D/E 0.04
  • Profitable in all of the last 5 years
  • Profit compounding 19% a year
  • Revenue barely growing (1% a year)
  • Small ₹18 cr company — thinner liquidity
3 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Colinz Laboratories Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.